IBM CEO: Watson Health is ‘Our Moonshot’ in Healthcare
By Greg Slabodkin,
Health Data Management
| 04. 20. 2015
Untitled Document
A new IBM business unit launched last week to help physicians, researchers, insurers and patients use big data, analytics and mobile technology to achieve better health outcomes is being described by the company’s chief executive officer as their “moonshot” in healthcare.
“If you go back in time, we have participated in some of the most glorious moments of history, whether it might have been the first systems that ever did census and landing a man on the moon,” said Ginni Rometty, chairman and CEO of IBM, on PBS’s Charlie Rose talk show. “I’m telling you our moonshot will be the impact we will have on healthcare. It has already started. We will do our part to change the face of healthcare. I am absolutely positive about it.”
Last week, IBM announced a new business unit—Watson Health—that will offer cloud-based access to its Watson supercomputer for analyzing healthcare data. Big Blue has partnered with Apple, Johnson & Johnson and Medtronic to make it easier for healthcare organizations to store and analyze patient data by leveraging Watson’s cognitive capabilities and...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...